These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4928 related items for PubMed ID: 19068343

  • 1. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M, Jurgens A, Lôo H, Olié JP, Amado I.
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [Abstract] [Full Text] [Related]

  • 2. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
    Odeberg H, Rodriguez-Silva B, Salander P, Mårtensson B.
    J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
    [Abstract] [Full Text] [Related]

  • 3. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K, Awata S, Takano T, Ebina Y, Iwasaki H, Matsuoka H.
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [Abstract] [Full Text] [Related]

  • 4. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F, Dor E, Benoit M, Dupuis G, Serret S, Myquel M, Seddiki Y.
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [Abstract] [Full Text] [Related]

  • 5. Maintenance electroconvulsive therapy: an alternative treatment for refractory schizophrenia and schizoaffective disorders.
    Lévy-Rueff M, Gourevitch R, Lôo H, Olié JP, Amado I.
    Psychiatry Res; 2010 Feb 28; 175(3):280-3. PubMed ID: 20034675
    [Abstract] [Full Text] [Related]

  • 6. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia.
    Chanpattana W, Chakrabhand ML, Kongsakon R, Techakasem P, Buppanharun W.
    J ECT; 1999 Jun 28; 15(2):129-39. PubMed ID: 10378152
    [Abstract] [Full Text] [Related]

  • 7. [Results of electroconvulsive therapy in restrictive indications. A retrospective study of 15 years].
    Schott K, Bartels M, Heimann H, Buchkremer G.
    Nervenarzt; 1992 Jul 28; 63(7):422-5. PubMed ID: 1501720
    [Abstract] [Full Text] [Related]

  • 8. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Nothdurfter C, Eser D, Schüle C, Zwanzger P, Marcuse A, Noack I, Möller HJ, Rupprecht R, Baghai TC.
    World J Biol Psychiatry; 2006 Jul 28; 7(3):162-70. PubMed ID: 16861142
    [Abstract] [Full Text] [Related]

  • 9. [Indications for electroconvulsive therapy].
    Boiteux J, Roubaud L, Gandelet N, Nezelof S, Vittouris N, Bonin B, Sechter D, Bizouard P.
    Encephale; 1997 Jun 28; 23 Spec No 3():21-6. PubMed ID: 9333557
    [Abstract] [Full Text] [Related]

  • 10. [Is electroconvulsive therapy obsolete?].
    König P, Angelberger-Spitaler H, Conca A, Schneider HJ.
    Wien Klin Wochenschr; 1991 Jun 28; 103(7):201-6. PubMed ID: 2063585
    [Abstract] [Full Text] [Related]

  • 11. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.
    Encephale; 2008 Dec 28; 34(6):557-62. PubMed ID: 19081451
    [Abstract] [Full Text] [Related]

  • 12. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM, Leucht S, Carpenter D, Docherty JP, Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders.
    J Clin Psychiatry; 2003 Dec 28; 64 Suppl 12():5-19. PubMed ID: 14640142
    [Abstract] [Full Text] [Related]

  • 13. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE, Wilson DR, Strakowski SM, McElroy SL, Kizer DL, Balistreri TM, Holtman HM, DePriest M.
    J Clin Psychiatry; 1995 Oct 28; 56(10):466-70. PubMed ID: 7559373
    [Abstract] [Full Text] [Related]

  • 14. [Use of electroconvulsive therapy in the adolescent].
    Cohen D, Dubos PF, Basquin M.
    Encephale; 1997 Oct 28; 23(4):308-11. PubMed ID: 9417397
    [Abstract] [Full Text] [Related]

  • 15. One-year follow-up after discontinuing maintenance electroconvulsive therapy.
    Huuhka K, Viikki M, Tammentie T, Tuohimaa K, Björkqvist M, Alanen HM, Leinonen E, Kampman O.
    J ECT; 2012 Dec 28; 28(4):225-8. PubMed ID: 22531209
    [Abstract] [Full Text] [Related]

  • 16. Naturalistic comparative study of outcome and cognitive effects of unmodified electro-convulsive therapy in schizophrenia, mania and severe depression in Nigeria.
    Ikeji OC, Ohaeri JU, Osahon RO, Agidee RO.
    East Afr Med J; 1999 Nov 28; 76(11):644-50. PubMed ID: 10734527
    [Abstract] [Full Text] [Related]

  • 17. [Prodromal symptoms in schizophrenic relapse: A descriptive and comparative study].
    Bouhlel S, Jones Y, Khelifa E, Msolly M, Melki W, El-Hechmi Z.
    Encephale; 2012 Oct 28; 38(5):397-403. PubMed ID: 23062453
    [Abstract] [Full Text] [Related]

  • 18. Maintenance ECT in schizophrenia: a pilot study.
    Chanpattana W.
    J Med Assoc Thai; 1998 Jan 28; 81(1):17-24. PubMed ID: 9470317
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial.
    Tang WK, Ungvari GS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May 28; 27(3):373-9. PubMed ID: 12691772
    [Abstract] [Full Text] [Related]

  • 20. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
    Nisijima K, Ishiguro T.
    J ECT; 1999 Jun 28; 15(2):158-63. PubMed ID: 10378156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 247.